Cluster Headaches are accepted to be because of a blend of ecological and hereditary components. Around 66% of cases keep running in families. Changing hormone levels might likewise assume a part, as headaches influence marginally a bigger number of young men than young ladies before pubescence, yet around a few times a larger number of ladies than men. The danger of headaches more often than not declines amid pregnancy.
All inclusive, around 15% of the populace is influenced by headaches sooner or later in life. As per the data of WHO the number of cluster headache cases are 175 numbers in the year 2014. The number of cluster headache cases are increasing day by day. This is a harmful type of headache. The number of persons suffering from cluster headache is increasing day by day. A variety of medications have been specifically designed to treat cluster headaches.
The FDA is currently reviewing a new migraine drug called Trexima, which combines the migraine drug Imitrex (sumitriptan) and naproxen sodium (a nonsteroidal anti-inflammatory drug) contained in Aleve and other over-the-counter medications. The triptan prevents blood vessels from dilating. This dilating leads to migraine pain; the anti-inflammatory drug prevents release of an inflammation-triggering enzyme, according to product developers.